Evidence has suggested that sterol regulatory element-binding protein 1c (SREBP1c) is a critical regulator governing lipid homeostasis in the liver and its neddylation is a potential therapeutic target for NAFLD [28]. The gene discussed is SREBF1; the disease is metabolic dysfunction-associated steatotic liver disease.